Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities
Nutrients · 16.01.2026 · 18 (2) · 290
DOI: 10.3390/nu18020290 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 16.01.2026. Verfasst von Julio Plaza-Diaz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Bioquímica i Biotecnologia, ANUT-DSM (Alimentaciò, Nutrició Desenvolupament i Salut Mental), Universitat Rovira i Virgili, 43201 Reus,…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Gastrointestinal Microbiome, Precision Medicine. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic syndrome, a clinical condition defined by central obesity, impaired glucose regulation, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol across the lifespan, is now a major public health issue typically managed with lifestyle, behavioral, and dietary recommendations. However, “one-size-fits-all” recommendations often yield modest, heterogeneous responses and poor long-term adherence, creating a clinical need for more targeted and implementable preventive and therapeutic strategies.
Objective
To synthesize evidence on how the gut microbiome can inform precision nutrition and exercise approaches for metabolic syndrome prevention and management, and to evaluate readiness for clinical translation. Key findings: The gut microbiome may influence cardiometabolic risk through microbe-derived metabolites and pathways involving short-chain fatty acids, bile acid signaling, gut barrier integrity, and low-grade systemic inflammation. Diet quality (e.g., Mediterranean-style patterns, higher fermentable fiber, or lower ultra-processed food intake) consistently relates to more favorable microbial functions, and intervention studies show that high-fiber/prebiotic strategies can improve glycemic control alongside microbiome shifts. Physical exercise can also modulate microbial diversity and metabolic outputs, although effects are typically subtle and may depend on baseline adiposity and sustained adherence. Emerging “microbiome-informed” personalization, especially algorithms predicting postprandial glycemic responses, has improved short-term glycemic outcomes compared with standard advice in controlled trials. Targeted microbiome-directed approaches (e.g., Akkermansia muciniphila-based supplementation and fecal microbiota transplantation) provide proof-of-concept signals, but durability and scalability remain key limitations.
Conclusions
Microbiome-informed personalization is a promising next step beyond generic guidelines, with potential to improve adherence and durable metabolic outcomes. Clinical implementation will require standardized measurement, rigorous external validation on clinically meaningful endpoints, interpretable decision support, and equity-focused evaluation across diverse populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departament de Bioquímica i Biotecnologia, ANUT-DSM (Alimentaciò, Nutrició Desenvolupament i Salut Mental), Universitat Rovira i Virgili, 43201 Reus, Spain.
- Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Spain.
- Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBERObn), Institute of Health Carlos III, 28029 Madrid, Spain.
- School of Health Sciences, Universidad Internacional de La Rioja, 26006 Logroño, Spain.
- Laboratory of Cellular and Molecular Gerontology, Precision Nutrition and Aging, Madrid Institute for Advanced Studies-IMDEA Nutrition, CEI UAM+CSIC, 28049 Madrid, Spain.
- AFySE Group, Research in Physical Activity and School Health, School of Physical Education, Faculty of Education, Universidad de Las Américas, Santiago 7500975, Chile.
ORCID-Profile: Julio Plaza-Diaz, Lourdes Herrera-Quintana, Jorge Olivares-Arancibia, Héctor Vázquez-Lorente
Zitieren
APA
Plaza-Diaz, J., Herrera-Quintana, L., Olivares-Arancibia, J., & Vázquez-Lorente, H. (2026). Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities. Nutrients, 18(2), 290. https://doi.org/10.3390/nu18020290
Vancouver
Plaza-Diaz J, Herrera-Quintana L, Olivares-Arancibia J, Vázquez-Lorente H. Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities. Nutrients. 2026;18(2):290. doi:10.3390/nu18020290
BibTeX
@article{PlazaDiaz2026,
author = {Plaza-Diaz, Julio and Herrera-Quintana, Lourdes and Olivares-Arancibia, Jorge and Vázquez-Lorente, Héctor},
title = {Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {2},
pages = {290},
doi = {10.3390/nu18020290}
}
EUVIMED